Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20103005 | 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde | 958230-19-8 | ≥97% |  |
| 171680 | Bexotegrast ( PLN-74809 ) | 2376257-44-0 | ≧98.0% |  |
| Bexotegrast (Synonyms: PLN-74809) is a small-molecule, dual selective inhibitor of α | ||||
| 18576 | VU0467154 | 1451993-15-9 | ≧98.0% |  |
| VU0467154 is a positive allosteric modulator of theM4 muscarinic acetylcholine recept | ||||
| 1711225 | Fosgonimeton (ATH-1017) | 2093305-05-4 | ≧98.0% |  |
| Fosgonimeton (ATH-1017) is a small molecule which enhance the activity of hepatocyte | ||||
| 171452 | BGB-15025 | 2766481-17-6 | ≧98.0% |  |
| BGB-15025 is a potent and selective HPK1 inhibitor that is efficacious as a single ag | ||||
| 52013 | ONX-0914 ( PR-957 ) | 960374-59-8 | ≧95.0% |  |
| ONX-0914, an inhibitor of the LMP7 and LMP2 subunits of immunoproteasomes, has activi | ||||
| 17021601 | LY3039478 ( Crenigacestat ) | 1421438-81-4 | ≧98.0% |  |
| LY3039478 ( Crenigacestat ), a selective NOTCH1 inhibitor, reduces intrahepatic chola | ||||
| 711401 | Eganelisib ( IPI-549 ) | 1693758-51-8 | ≧98.0% |  |
| Eganelisib (IPI-549) is a first-in-class, orally administered, highly selective PI3Kγ | ||||
| 24067 | PBT434 Hydrobromide | 1232841-78-9 | ≧98.0% |  |
| PBT434, also known as ATH434 , is a novel, brain-penetrant, inhibitor of α-synuclein | ||||
| 233141 | NXP-800 ( CCT361814 ) | 1693734-80-3 | ≧98.0% |  |
| NXP800 is an oral small molecule inhibitor of the Heat Shock Factor 1 (HSF1) pathway. | ||||
| 20646 | TNG908 | 2760481-53-4 | ≧98.0% |  |
| TNG908 is a clinical stage MTA-cooperative PRMT5 inhibitor that is selectively active | ||||
| 20313 | Cenerimod ( ACT-334441 ) | 1262414-04-9 | ≧98.0% |  |
| Cenerimod is a potent and orally active immunomodulator, exhibited EC50 value of 2.7 | ||||